Clinical Trials | Medical XPRT

Articles & Whitepapers

The Reality and Future of Peptide Drugs

It has been said that the 21st century is the century of peptide drugs, and the fate of this substance, which lies between a large protein and a small molecule compound, is bound to be extraordinary. What are peptide drugs? Peptides are a class of compounds made up of amino acids linked by peptide bonds and are chemically active substances commonly found in living organisms. According to the ...

Developing Research and Medical Diagnostic Products

The demand for research and MEDICAL DIAGNOSTIC products grows annually. Because medical diagnostic devices are used in the testing, treatment, prevention, monitoring, studying, and diagnosis of ...

Global ADC Drug Overview

Structure-based Design of Protein Kinase Inhibitors

What are the ADC drugs?

News

Lonza to Establish Drug Product Manufacturing Services in Guangzhou, China

As part of Lonza's continued investment in China, a new drug product fill and finish manufacturing line will be installed at its Guangzhou (CN) site The investment will establish drug product manufacturing capacity for clinical trial and ...

Recruitment of the smallest infants in the Connection study paused

Indee Labs Awarded Grant from the National Institute of Allergy & Infectious Disease

Lonza to Establish Drug Product Manufacturing Services in Guangzhou, China

Creative Proteomics Accelerates Life Science Research Through Mass Spectrometry Platform

Equipment & Solutions

Showcase

BioVOC-2 Breath Sampler

Markes’ BioVOC-2™ breath sampler is a lightweight and simple-to-use device designed for non-invasive biological exposure monitoring of VOCs. Using a design pioneered by the UK Health & Safety Executive, BioVOC-2 collects the last 129 mL of expired breath for transfer to a sorbent tube, and subsequent analysis by thermal desorption. BioVOC-2 is for research use only. Not for use in ...

Upcoming Events

Showcase

Cell & Gene Meeting on the Mesa 2021

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to ...